ATE258430T1 - Zubereitung mit verzögerter wirkstoffabgabe für aii antagonisten, ihre herstellung und verwendung - Google Patents

Zubereitung mit verzögerter wirkstoffabgabe für aii antagonisten, ihre herstellung und verwendung

Info

Publication number: ATE258430T1
Authority: AT; Austria
Prior art keywords: preparation; production; delayed release; aii antagonists; angiotensin
Prior art date: 1998-03-04

Application number

AT99907846T

Other languages

English (en)

Inventor

Yasutaka Igari

Akira Saikawa

Yoshiyuki Inada

Shigeru Kamei

Original Assignee

Takeda Chemical Industries Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-03-04

Filing date

1999-03-03

Publication date

2004-02-15

1999-03-03 Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd

2004-02-15 Application granted granted Critical

2004-02-15 Publication of ATE258430T1 publication Critical patent/ATE258430T1/de

Links

239000005557 antagonist Substances 0.000 title 1
230000003111 delayed effect Effects 0.000 title 1
102000005862 Angiotensin II Human genes 0.000 abstract 2
101800000733 Angiotensin-2 Proteins 0.000 abstract 2
CZGUSIXMZVURDU-JZXHSEFVSA-N Ile(5)-angiotensin II Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C([O-])=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=[NH2+])NC(=O)[C@@H]([NH3+])CC([O-])=O)C(C)C)C1=CC=C(O)C=C1 CZGUSIXMZVURDU-JZXHSEFVSA-N 0.000 abstract 2
229950006323 angiotensin ii Drugs 0.000 abstract 2
230000003042 antagnostic effect Effects 0.000 abstract 2
229920002988 biodegradable polymer Polymers 0.000 abstract 1
239000004621 biodegradable polymer Substances 0.000 abstract 1
230000036772 blood pressure Effects 0.000 abstract 1
230000027288 circadian rhythm Effects 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
239000003405 delayed action preparation Substances 0.000 abstract 1
239000002184 metal Substances 0.000 abstract 1
229940002612 prodrug Drugs 0.000 abstract 1
239000000651 prodrug Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Inorganic Chemistry (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Plural Heterocyclic Compounds (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT99907846T 1998-03-04 1999-03-03 Zubereitung mit verzögerter wirkstoffabgabe für aii antagonisten, ihre herstellung und verwendung ATE258430T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP5236698		1998-03-04
PCT/JP1999/001011 WO1999044590A1 (en)	1998-03-04	1999-03-03	Sustained-release preparation for aii antagonist, production and use thereof

Publications (1)

Publication Number	Publication Date
ATE258430T1 true ATE258430T1 (de)	2004-02-15

Family

ID=12912818

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT99907846T ATE258430T1 (de)	1998-03-04	1999-03-03	Zubereitung mit verzögerter wirkstoffabgabe für aii antagonisten, ihre herstellung und verwendung

Country Status (21)

Country	Link
US (2)	US6589547B1 (de)
EP (1)	EP1058541B1 (de)
KR (1)	KR20010086245A (de)
CN (1)	CN1291888A (de)
AT (1)	ATE258430T1 (de)
AU (1)	AU2745199A (de)
BR (1)	BR9908474A (de)
CA (1)	CA2318446C (de)
DE (1)	DE69914460T2 (de)
EE (1)	EE200000499A (de)
ES (1)	ES2214013T3 (de)
HU (1)	HUP0101439A3 (de)
ID (1)	ID25640A (de)
IL (1)	IL137979A0 (de)
LT (1)	LT4800B (de)
LV (1)	LV12585B (de)
NO (1)	NO20004350L (de)
PL (1)	PL342684A1 (de)
SK (1)	SK11902000A3 (de)
WO (1)	WO1999044590A1 (de)
ZA (1)	ZA991706B (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2214013T3 (es) *	1998-03-04	2004-09-01	Takeda Chemical Industries Ltd	Preparacion de liberacion sostenida para un antagonista de aii, su produccion y su uso.
WO2000066161A1 (en)	1999-04-28	2000-11-09	Takeda Chemical Industries, Ltd.	Preventives / remedies / progression inhibitors for simplex retinopathy or preproliferating retinopathy
SE9903028D0 (sv) *	1999-08-27	1999-08-27	Astra Ab	New use
HUP0203326A3 (en)	1999-08-30	2003-04-28	Sanofi Aventis Deutschland	Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events
PL356422A1 (en) *	2000-02-18	2004-06-28	Takeda Chemical Industries, Ltd.	Tnf-alpha inhibitors
US20030068374A1 (en) *	2000-02-21	2003-04-10	Shigeru Kamei	Sustained release preparations of physiologically active compound hardly soluble in water and production process and use of the same
CA2420055C (en) *	2000-08-25	2010-06-01	Takeda Chemical Industries, Ltd.	Fibrinogen-lowering agent
US20040102502A1 (en) *	2000-10-25	2004-05-27	Toshifumi Watanabe	Preventing/remedies for portal hypertension
WO2002074340A1 (fr) *	2001-03-16	2002-09-26	Takeda Chemical Industries, Ltd.	Procede de fabrication d'une preparation a liberation continue
US20040219208A1 (en) *	2001-08-03	2004-11-04	Ryu Kawamura	Sustained-release medicines
BRPI0105509B8 (pt) *	2001-11-05	2021-05-25	Univ Minas Gerais	formulações do peptídeo angiotensina-(1-7) usando as ciclodextrinas, lipossomas e o polímero plga
EP1444988A4 (de) *	2001-11-13	2007-04-25	Takeda Pharmaceutical	Krebsmittel
AU2002349673A1 (en) *	2001-12-03	2003-06-17	Takeda Chemical Industries, Ltd.	Insulin resistance improving agents
US7407778B2 (en) *	2002-02-07	2008-08-05	Pettegrew Jay W	Compounds, compositions and methods for treating neuropsychiatric disorders
US7700074B2 (en) *	2002-02-07	2010-04-20	Pettegrew Jay W	Method and system for diagnosis of neuropsychiatric disorders including chronic alcoholism
ATE551056T1 (de) *	2002-12-27	2012-04-15	Takeda Pharmaceutical	Mittel zur hemmung der körpergewichtszunahme
US20050038093A1 (en) *	2003-05-02	2005-02-17	Boehringer Ingelheim International Gmbh	Treating diabetic retinopathy with angiotensin II receptor blockers
US20060257842A1 (en) *	2003-05-29	2006-11-16	Pettegrew Jay W	Cryopreservation media and molecules
WO2004110963A2 (en) *	2003-05-29	2004-12-23	Pettegrew Jay W	Glycerophosphocholine and its derivatives for medical imaging neuropsychiatric disorders
WO2005097109A1 (en) *	2004-04-01	2005-10-20	Daniel Batlle	Methods for achieving a protective ace2 expression level
CA2568640C (en)	2004-06-04	2011-08-09	Teva Pharmaceutical Industries Ltd.	Pharmaceutical composition containing irbesartan
UY29155A1 (es) *	2004-10-07	2006-02-24	Takeda Pharmaceutical	Un agente para la profilaxis o tratamietno del sindrome metabolico
EP1806137A4 (de) *	2004-10-29	2011-03-30	Kowa Co	Therapeutischer wirkstoff zur behandlung von glomerulärer erkrankung
EP1850835A1 (de) *	2005-02-21	2007-11-07	Flamel Technologies	Orale pharmazeutische form von losartan
NZ562887A (en) *	2005-03-30	2010-10-29	Takeda Pharmaceutical	Benzimidazole derivative and use as angiotensin II antagonist
WO2007032019A2 (en) *	2005-08-22	2007-03-22	Alembic Limited	Process for preparing valsartan
GEP20125420B (en) *	2006-08-10	2012-03-26	Takeda Pharmaceutical	Solid pharmaceutical composition comprising benzimidazole compound
PE20081364A1 (es) *	2006-09-04	2008-12-04	Novartis Ag	Composicion farmaceutica que comprende valsartan
EP1897537A1 (de) *	2006-09-04	2008-03-12	Novartis AG	Zusammensetzung enthaltend einen Angiotensin II antagonisten
EP1908469A1 (de)	2006-10-06	2008-04-09	Boehringer Ingelheim Vetmedica Gmbh	Angiotensin II Rezeptor Antagonisten zur Behandlung von systemischen Krankheiten bei Katzen
JP4564098B2 (ja)	2006-12-18	2010-10-20	武田薬品工業株式会社	徐放性組成物およびその製造法
CN101011393B (zh) *	2007-02-16	2010-10-06	广州柏赛罗药业有限公司	厄贝沙坦胃内滞留型缓释药物组合物
AR065850A1 (es) *	2007-03-28	2009-07-08	Takeda Pharmaceutical	Composicion farmaceutica solida que comprende un derivado de benzimidazol-7-carboxilato y un agente de control de ph
US20110117194A1 (en) *	2008-04-29	2011-05-19	Hanall Biopharma Co., Ltd.	Pharmaceutical formulation containing angiotensin-ii receptor blocker
SG176585A1 (en)	2009-05-20	2012-01-30	Boehringer Ingelheim Vetmed	Pharmaceutical oral telmisartan solution
WO2018002673A1 (en)	2016-07-01	2018-01-04	N4 Pharma Uk Limited	Novel formulations of angiotensin ii receptor antagonists
EP3996709A1 (de)	2019-07-09	2022-05-18	Boehringer Ingelheim Vetmedica GmbH	Telmisartan zur behandlung von bluthochdruck bei hunden

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2751907A (en) *	1953-09-18	1956-06-26	Bishop & Co Platinum Works J	Pellet injector
JPS5671073A (en)	1979-11-12	1981-06-13	Takeda Chem Ind Ltd	Imidazole derivative
JPS5671074A (en)	1979-11-12	1981-06-13	Takeda Chem Ind Ltd	1,2-disubstituted-4-halogenoimidazole-5-acetic acid derivative
IE802177L (en)	1980-10-21	1981-05-12	Takeda Chemical Industries Ltd	Imidazol-5-ylacetic acid derivatives
JPS58157768A (ja)	1982-03-16	1983-09-19	Takeda Chem Ind Ltd	４−クロロ−２−フエニルイミダゾ−ル−５−酢酸誘導体
CA1334092C (en)	1986-07-11	1995-01-24	David John Carini	Angiotensin ii receptor blocking imidazoles
US4820843A (en)	1987-05-22	1989-04-11	E. I. Du Pont De Nemours And Company	Tetrazole intermediates to antihypertensive compounds
CA1338238C (en)	1988-01-07	1996-04-09	David John Carini	Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
US5015651A (en)	1988-01-07	1991-05-14	E. I. Du Pont De Nemours And Company	Treatment of hypertension with 1,2,4-angiotensin II antagonists
US4880804A (en)	1988-01-07	1989-11-14	E. I. Du Pont De Nemours And Company	Angiotensin II receptor blocking benzimidazoles
US4898732A (en) *	1988-05-04	1990-02-06	The Clinipad Corporation	Inhibiting of tumor growth with an antagonist of the renin-angioten-sin system
DE3928177A1 (de)	1989-04-08	1991-02-28	Thomae Gmbh Dr K	Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
IE64514B1 (en)	1989-05-23	1995-08-09	Zeneca Ltd	Azaindenes
EP0399432B1 (de) *	1989-05-25	1994-06-22	Takeda Chemical Industries, Ltd.	Transdermales therapeutisches Mittel
EP0403158A3 (de)	1989-06-14	1991-12-18	Smithkline Beecham Corporation	Imidazolyl-Alkensäuren
HU217958B (hu)	1989-06-30	2000-05-28	E. I. Du Pont De Nemours And Co.	Helyettesített imidazolszármazékok, ezeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
CA2020073A1 (en)	1989-07-03	1991-01-04	Eric E. Allen	Substituted quinazolinones as angiotensin ii antagonists
EP0407342A3 (en)	1989-07-06	1991-07-10	Ciba-Geigy Ag	Pyrimidine derivatives
EP0409332A3 (en)	1989-07-19	1991-08-07	Merck & Co. Inc.	Substituted triazoles as angiotensin ii antagonists
US5225205A (en) *	1989-07-28	1993-07-06	Debiopharm S.A.	Pharmaceutical composition in the form of microparticles
DE69013607T2 (de)	1989-08-02	1995-03-02	Takeda Chemical Industries Ltd	Pyrazol-Derivate, Verfahren zu deren Herstellung und Anwendung.
IL95975A (en)	1989-10-24	1997-06-10	Takeda Chemical Industries Ltd	N-benzyl- 2-alkylbenzimidazole derivatives, their production and pharmaceutical compositions containing them
EP0434038A1 (de)	1989-12-22	1991-06-26	Takeda Chemical Industries, Ltd.	Kondensierte Imidazolderivate, ihre Herstellung und Verwendung
US5162326A (en)	1990-02-15	1992-11-10	Takeda Chemical Industries, Ltd.	Pyrimidinedione derivatives, their production and use
CA2036618C (en) *	1990-02-22	2002-10-29	Akira Morimoto	Fused thiophene derivatives, their production and use
IE912956A1 (en) *	1990-09-10	1992-03-11	Abbott Lab	Angiotensin ii receptor antagonists
US5171217A (en) *	1991-02-28	1992-12-15	Indiana University Foundation	Method for delivery of smooth muscle cell inhibitors
TW274551B (de)	1991-04-16	1996-04-21	Takeda Pharm Industry Co Ltd
JPH06510763A (ja) *	1991-08-19	1994-12-01	イー・アイ・デュポン・ドゥ・ヌムール・アンド・カンパニー	アンジオテンシン２受容体遮断イミダゾリノン誘導体
TW284688B (de) *	1991-11-20	1996-09-01	Takeda Pharm Industry Co Ltd
US5656297A (en)	1992-03-12	1997-08-12	Alkermes Controlled Therapeutics, Incorporated	Modulated release from biocompatible polymers
GB2272899A (en) *	1992-11-30	1994-06-01	Du Pont Merck Pharma	Angiotensin-11 receptor blocking cycloalkylbenzylimidazoles
EP0603712B1 (de)	1992-12-22	2001-08-16	Takeda Chemical Industries, Ltd.	Heterocyclische Verbindungen mit Angiotensin-II-antagonistischer Wirkung und ihre Anwendung
US5288720A (en) *	1993-04-23	1994-02-22	American Cyanamid Company	Angiotensin II receptor blocking 2,3,6 substituted quinazolinones
US5721263A (en) *	1993-06-07	1998-02-24	Takeda Chemical Industries, Ltd.	Pharmaceutical composition for angiotensin II-mediated diseases
CN1502331A (zh) *	1993-07-19	2004-06-09	Ѫ�ܼ��ҩ�﹫˾	抗血管生长组合物及使用方法
JPH0789849A (ja)	1993-09-20	1995-04-04	Fujisawa Pharmaceut Co Ltd	徐放性製剤
WO1997001331A2 (en) *	1995-06-27	1997-01-16	Takeda Chemical Industries, Ltd.	Method of producing sustained-release preparation
AR006439A1 (es)	1996-03-29	1999-08-25	Smithkline Beecham Corp	Dihidrato de eprosartano y un procedimiento para su produccion y formulacion
GB9613470D0 (en) *	1996-06-27	1996-08-28	Ciba Geigy Ag	Small solid oral dosage form
US6201002B1 (en) *	1997-01-10	2001-03-13	Merck & Co., Inc.	Method for reducing mortality with an angiotensin II antagonist
US5958884A (en) *	1997-04-11	1999-09-28	The Brigham And Women's Hospital, Inc.	Compositions and methods for treating erectile dysfunction
US6306826B1 (en) *	1997-06-04	2001-10-23	The Regents Of The University Of California	Treatment of heart failure with growth hormone
DE19741635A1 (de) *	1997-09-22	1999-03-25	Hoechst Marion Roussel De Gmbh	Biphenylsulfonylcyanamide, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament
ES2214013T3 (es) *	1998-03-04	2004-09-01	Takeda Chemical Industries Ltd	Preparacion de liberacion sostenida para un antagonista de aii, su produccion y su uso.

1999
- 1999-03-03 ES ES99907846T patent/ES2214013T3/es not_active Expired - Lifetime
- 1999-03-03 ZA ZA9901706A patent/ZA991706B/xx unknown
- 1999-03-03 AT AT99907846T patent/ATE258430T1/de not_active IP Right Cessation
- 1999-03-03 AU AU27451/99A patent/AU2745199A/en not_active Abandoned
- 1999-03-03 KR KR1020007008919A patent/KR20010086245A/ko not_active Abandoned
- 1999-03-03 WO PCT/JP1999/001011 patent/WO1999044590A1/en not_active Ceased
- 1999-03-03 IL IL13797999A patent/IL137979A0/xx unknown
- 1999-03-03 SK SK1190-2000A patent/SK11902000A3/sk unknown
- 1999-03-03 CN CN99803444A patent/CN1291888A/zh active Pending
- 1999-03-03 ID IDW20001680A patent/ID25640A/id unknown
- 1999-03-03 EE EEP200000499A patent/EE200000499A/xx unknown
- 1999-03-03 EP EP99907846A patent/EP1058541B1/de not_active Expired - Lifetime
- 1999-03-03 DE DE69914460T patent/DE69914460T2/de not_active Expired - Lifetime
- 1999-03-03 BR BR9908474-0A patent/BR9908474A/pt not_active IP Right Cessation
- 1999-03-03 PL PL99342684A patent/PL342684A1/xx unknown
- 1999-03-03 HU HU0101439A patent/HUP0101439A3/hu unknown
- 1999-03-03 CA CA002318446A patent/CA2318446C/en not_active Expired - Fee Related
- 1999-03-09 US US09/601,986 patent/US6589547B1/en not_active Expired - Fee Related
2000
- 2000-08-16 LV LVP-00-110A patent/LV12585B/en unknown
- 2000-08-31 LT LT2000082A patent/LT4800B/lt not_active IP Right Cessation
- 2000-09-01 NO NO20004350A patent/NO20004350L/no unknown
2003
- 2003-05-22 US US10/443,308 patent/US7294344B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP1058541B1 (de)	2004-01-28
LT2000082A (en)	2001-03-26
CA2318446C (en)	2008-09-23
NO20004350L (no)	2000-10-03
ES2214013T3 (es)	2004-09-01
LV12585B (en)	2001-03-20
SK11902000A3 (sk)	2001-02-12
ID25640A (id)	2000-10-19
ZA991706B (en)	2000-10-03
LV12585A (en)	2000-12-20
HUP0101439A2 (hu)	2001-10-28
IL137979A0 (en)	2001-10-31
EE200000499A (et)	2002-02-15
EP1058541A1 (de)	2000-12-13
KR20010086245A (ko)	2001-09-10
US20030198676A1 (en)	2003-10-23
AU2745199A (en)	1999-09-20
US6589547B1 (en)	2003-07-08
US7294344B2 (en)	2007-11-13
NO20004350D0 (no)	2000-09-01
BR9908474A (pt)	2000-12-05
DE69914460D1 (de)	2004-03-04
DE69914460T2 (de)	2004-10-28
CA2318446A1 (en)	1999-09-10
HUP0101439A3 (en)	2002-09-30
WO1999044590A1 (en)	1999-09-10
PL342684A1 (en)	2001-07-02
CN1291888A (zh)	2001-04-18
LT4800B (lt)	2001-06-25

Legal Events

Date

Code

Title

Description

2004-09-15

UEP

Publication of translation of european patent specification

Ref document number: 1058541

Country of ref document: EP

2011-12-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
DE69914460D1 (de)	2004-03-04	Zubereitung mit verzögerter wirkstoffabgabe für aii antagonisten, ihre herstellung und verwendung
EA200100678A1 (ru)	2001-12-24	N-уреидоалкил-пиперидины в качестве модуляторов активности рецепторов хемокинов
DE69926919D1 (de)	2005-09-29	N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren
BR0014651A (pt)	2002-06-18	Inibidores de adesão de célula mediada por "alfa" l beta2
DE60119397D1 (de)	2006-06-08	"2-Oxo-1-Pyrrolidinderivate und ihre pharmazeutische Verwendung"
TR200200579T2 (tr)	2002-12-23	Amino-tirazolpiridin türevleri.
DK0976722T3 (da)	2009-05-04	Benzamidin-derivater
PT863875E (pt)	2003-10-31	Novos compostos 4-(oxialcoxifenil)-3-oxi-piperidina para o tratamento de insuficiencia cardiaca e renal
DE69841307D1 (de)	2010-01-07	Verwendung von peroxiden zur bekämpfung der haarigen warzenerkrankung
ATE272398T1 (de)	2004-08-15	Verwendung von ep4 rezeptorliganden zur behandlung von neuropathischen schmerz
FR2790955B1 (fr)	2003-01-17	Utilisation d'oligonucleotides stabilises comme principe actif antitumoral
BG105112A (bg)	2001-10-31	Средство с антидепресивно действие
ATE435648T1 (de)	2009-07-15	Derivaten von nodulisporen säure
BR9804027A (pt)	2001-04-24	Novos beta-ceto ésteres
EA200200742A1 (ru)	2002-12-26	1,2-диарилбензимидазолы для лечения заболеваний, связанных с активацией микроглии
DE69841267D1 (de)	2009-12-10	Verwendung von r-carprofen zur Vorbeugung der Alzheimerschen Krankheit
ECSP045075A (es)	2004-05-28	Endoprotesis vasculares ("stents")"
ATE201680T1 (de)	2001-06-15	2,3,4,5-tetrahydro-1h-3-benzazepin säure- additions-salze
TR199800165T1 (xx)	1998-06-22	(R)-5-bromo-n-(1-etil-4-metil hekzahidro-1h-1,4-diazepin-6-il)-2-metoksi-6- metilamino-3-piridinkarboksamid, bunu haz�rlamaya mahsus y�ntem ve bu bile�i�i ihtiva eden farmas�tik terkip.
EA200701181A1 (ru)	2008-02-28	Лекарственные средства, предназначенные для лечения или предупреждения фиброзных заболеваний
DE60028928D1 (de)	2006-08-03	Verwendung von angiotensin ii rezeptorantagonisten zur behandlung von akutem myokardischen infarkt
ATE360423T1 (de)	2007-05-15	Verwendung von chymase hemmern gegen vaskuläre lipidablagerung
TR200001080T2 (tr)	2001-01-22	2 ile ikame edilmiş 1,2-Benisotiyazol türevleri ve bunların serrotonın antagonistleri
PL403800A1 (pl)	2013-08-19	Kompozycja farmaceutyczna
EP1062949A4 (de)	2002-10-09	INHIBITOREN DER IgE ANTIKÖRPERPRODUKTION UND INHIBITOREN VON AUTOIMUNKRANKHEITEN